Commercial and medical teams never used to get along. For decades they seemed at odds: the jocks vs the nerds; the gunslingers vs the boffins. But now it’s 2024, and this description is way out of date.
Yet some of the reasons persist. Both sides still play different sports. From misaligned objectives to touchy compliance questions to ambiguous ROIs, it’s no wonder they haven’t been able to score in the same goal very often. However, as both medical and commercial teams become more data-driven, their differences are reducing. Convergence is now inevitable, if still painful.
There is an answer. By harnessing automation technologies, our industry is within touching distance of achieving successful end-to-end operations between medical and commercial teams. All we need after that is a process to implement it. That process is the M–C matrix, and this whitepaper will show you how it works.
Paul Simms
Chief Executive, Impatient Health
Paul Simms Chief Executive Impatient Health Read more
Paul Rowe Vice President, Head of Medical, Specialty Care, North America Sanofi
Florent Edouard SVP, Global Head of Commercial Excellence Grünenthal Group
Erasmus Holm Director, Pharma & Commercial Operations MSD Netherlands
Patrick Laroche Vice President Medical Affairs, Operational Excellence Strategy EMEA The Janssen Pharmaceutical Companies of Johnson & Johnson
Emma Vitalini Head of Global Medical Digital Strategy Amgen
Evjatar Cohen Industry Leader, Life Sciences Appian Corporation
Tiana Homsani Global Head of Marketing Excellence Abbott
Danie Du Plessis Executive Vice President Medical Affairs Kyowa Kirin International plc
This paper brings practical, implementable solutions, informed by top industry leaders, to show how there is a better, more efficient and more profitable solution to medical–commercial collaboration.
Download your copy of the whitepaper